in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Novozymes Breaks Ground in China for Hyaluronic Acid Unit
12:03 AM MDT | May 11, 2009 | DEEPTI RAMESH
Novozymes says it has broken ground on a facility to produce bacillus-based hyaluronic acid (bHA) at its existing Tianjin, China site. The company is also considering establishing a cluster of facilities at the site to produce bulk active pharmaceutical ingredients, which would facilitate expansion as business opportunities develop, Novozymes says. Novozymes expects to invest $35 million–$50 million to build the plant, which is set to be completed in first-quarter 2011. ...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee